{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:20:29Z","timestamp":1748406029682,"version":"3.41.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To compare the long-term adverse events of intensity-modulated radiation therapy (IMRT) with those of 3-dimensional conformal radiation therapy (3D-CRT) in patients with intermediate-risk and high-risk uterine cervical cancer who underwent postoperative pelvic radiation therapy (PORT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We reviewed the medical records of 177 patients with cervical cancer who underwent radical surgery and PORT. IMRT and 3D-CRT were administered to 93 and 84 patients, respectively. Follow-up and toxicity assessments were then carried out.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The median follow-up period was 63 months (range: 3 to 177). There was a significant difference in the follow-up period between the IMRT and 3D-CRT cohorts (median: 59 vs. 112\u00a0mo, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). The crude incidences of acute grade 2+ and grade 3+ gastrointestinal toxicities were significantly lower with IMRT than with 3D-CRT (22.6% vs. 48.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.002, and 3.2% vs. 11.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.04, respectively). The Kaplan-Meier estimates of late toxicities revealed that IMRT significantly reduced grade 2+ genitourinary (GU) toxicity and lower-extremity lymphedema ([LEL] requiring intervention) compared with 3D-CRT ([6.8% vs. 15.2% at 5-year, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.048] and [3.1% vs. 14.6% at 5-year, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0029], respectively). IMRT was the only significant predictor of reducing LEL risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The risks of acute gastrointestinal toxicity, late GU toxicity, and LEL from PORT for cervical cancer were reduced by IMRT. Lower inguinal doses may have contributed to a lower risk of developing LEL, which should be validated in future studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000001018","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:03:49Z","timestamp":1685073829000},"page":"346-352","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Reduced Risk of Lymphedema With Intensity-modulated Radiation Therapy Compared With 3-dimensional Conformal Radiation Therapy in Patients With Cervical Cancer Who Received Postoperative Pelvic Radiation Therapy"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5736-5655","authenticated-orcid":false,"given":"Haruka","family":"Uezono","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Tsujino","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Marudai","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Bessyo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatamei","family":"Takabayashi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ygyno.2005.03.017","article-title":"Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study","volume":"97","author":"Yamashita","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.19.02381","article-title":"Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG oncology RTOG 1203 study","volume":"38","author":"Yeung","year":"2020","journal-title":"J Clin Oncol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13014-015-0486-5","article-title":"Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters","volume":"10","author":"Isohashi","year":"2015","journal-title":"Radiat Oncol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","article-title":"Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies","volume":"52","author":"Mundt","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jrr\/rrt055","article-title":"Pelvic insufficiency fracture after definitive radiotherapy for uterine cervical cancer: retrospective analysis of risk factors","volume":"54","author":"Uezono","year":"2013","journal-title":"J Radiat Res"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jrr\/rrz070","article-title":"Prospective observational study on the safety of an original fiducial marker insertion for radiotherapy in gynecological cancer by a simple method","volume":"60","author":"Sekii","year":"2019","journal-title":"J Radiat Res"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/jjco\/hyp191","article-title":"A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer","volume":"40","author":"Toita","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jjco\/hyz098","article-title":"Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402)","volume":"49","author":"Murakami","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2006.11.005","article-title":"Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy","volume":"67","author":"Chen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/cancers14030807","article-title":"The impact of an incidental dose on axillary tumor control and toxicity in localized breast cancer: a retrospective analysis","volume":"14","author":"Schmitt","year":"2022","journal-title":"Cancers"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/SLA.0000000000003491","article-title":"Risk of lymphedema following contemporary treatment for breast cancer","volume":"274","author":"Byun","year":"2021","journal-title":"Ann Surg"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3390\/cancers13092113","article-title":"The lymph-sparing quotient: a retrospective risk analysis on extremity radiation for soft tissue sarcoma treatment","volume":"13","author":"Sarif","year":"2021","journal-title":"Cancers"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"104856","DOI":"10.1016\/j.oraloncology.2020.104856","article-title":"Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio(chemo)therapy-results of a longitudinal study","volume":"109","author":"Tribius","year":"2020","journal-title":"Oral Oncol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12905-017-0403-1","article-title":"Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study","volume":"17","author":"Kuroda","year":"2017","journal-title":"BMC Women\u2019s Health"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.3802\/jgo.2016.27.e4","article-title":"The risk of lymphedema after postoperative radiation therapy in endometrial cancer","volume":"27","author":"Mitra","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"R24-20250527","first-page":"61","article-title":"Type of collateral lymphatic circulation","volume":"7","author":"Bruna","year":"1974","journal-title":"Lymphology"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"e001896","DOI":"10.1136\/bmjopen-2012-001896","article-title":"Protocol for a phase III randomized trial of image-guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late small bowel toxicity reduction after postoperative adjuvant radiation in Ca cervix","volume":"2","author":"Chopra","year":"2012","journal-title":"BMJ Open"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/bjs.1800730723","article-title":"Risk of lymphoedema following the treatment of breast cancer","volume":"73","author":"Kissin","year":"1986","journal-title":"Br J Surg"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"596","DOI":"10.21037\/gs.2020.03.20","article-title":"The impact of radiation on lymphedema: a review of the literature","volume":"9","author":"Allam","year":"2020","journal-title":"Gland Surg"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:01:51Z","timestamp":1748376111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000001018","relation":{},"ISSN":["0277-3732"],"issn-type":[{"type":"print","value":"0277-3732"}],"subject":[],"published":{"date-parts":[[2023,5,26]]}}}